Global Injectable Drug Delivery market is Expected to reach $1199.89 billion by 2026 with a CAGR of 12.8% - Baxter International, ELI Lilly and Company, Terumo, Becton, Dickinson and Company, Pfizer

Global Injectable Drug Delivery market is expected to grow from $404.14 billion in 2017 to reach $1199.89 billion by 2026 with a CAGR of 12.8%. Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles is hampering the market growth.

Get Sample Copy at https://www.reportsweb.com/inquiry&RW00012218026/sample

Drug delivery is the method of administering a pharmaceutical compound into the body through different routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by passing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. It is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson's disease, hemophilia, hepatitis C and ribose-5-phosphate isomerase deficiency.

Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition they offer better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.

By Geography, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.

Some of the key players in the Injectable Drug Delivery market include Baxter International, Inc., ELI Lilly and Company, Terumo Corporation, Becton, Dickinson and Company, Pfizer, Inc., Gerresheimer AG, Teva Pharmaceutical Industries Ltd., Schott AG, Sandoz, Antares Pharma, Inc., Zogenix, Inc., Scandinavian Health Limited, Terumo Medical Corp., Ypsomed Holding AG, Unilife Corporation, Vetter Pharma-Fertigung GmbH & Co. KG and Nova Nordisk A/S.

Types Covered:
-Formulations
-Devices

Formulation Packagings Covered:
-Cartridges
-Ampules
-Bottles
-Vials

Usage Patterns Covered:
-Immunization
-Curative Care
-Other Usage Patterns

Facility of Uses Covered:
-Home Care Settings
-Hospitals and Clinics
-Other Facilities of Use

Site of Administrations Covered:
-Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
-Skin (Intradermal and Subcutaneous)
-Central Nervous System (Intracerebral and Intrathecal)
-Organs (Intravitreal and Intra-Articular)

Make an Inquiry https://www.reportsweb.com/inquiry&RW00012218026/buying

Table of Contents:

1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Injectable Drug Delivery Market, By Type
6 Global Injectable Drug Delivery Market, By Formulation Packaging
7 Global Injectable Drug Delivery Market, By Usage Pattern
8 Global Injectable Drug Delivery Market, By Facility of Use
9 Global Injectable Drug Delivery Market, By Site of Administration
10 Global Injectable Drug Delivery Market, By Application
11 Global Injectable Drug Delivery Market, By Distribution Channel
12 Global Injectable Drug Delivery Market, By End User
13 Global Injectable Drug Delivery Market, By Geography
14 Key Developments
15 Company Profiling
15.1 Baxter International, Inc.
15.2 ELI Lilly and Company
15.3 Terumo Corporation
15.4 Becton, Dickinson and Company
15.5 Pfizer, Inc.
15.6 Gerresheimer AG
15.7 Teva Pharmaceutical Industries Ltd.
15.8 Schott AG
15.9 Sandoz
15.1 Antares Pharma, Inc.,
15.11 Zogenix, Inc.
15.12 Scandinavian Health Limited
15.13 Terumo Medical Corp.,
15.14 Ypsomed Holding AG
15.15 Unilife Corporation,
15.16 Vetter Pharma-Fertigung GmbH & Co. KG.
15.17 Nova Nordisk A/S

For More Information about This Report: https://www.reportsweb.com/reports/injectable-drug-delivery-global-market-outlook-2017-2026

Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

Pune, India

ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

This release was published on openPR.